Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Inocycle Technology Group Tbk. (INOV) Price & Performance

Indofarma Tbk.Trade
Inocycle Technology Group Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Inocycle Technology Group Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Inocycle Technology Group Tbk. trades at Rp138 (market cap 253.15B, 4.59M 24h volume). The key difference: Indofarma Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

INAFINOV
Market Cap
390.51B253.15B
Volume
4.59M
Lot
45.92K
Turnover
648.5M
Average Price
141.24
Value
648.5M
Indicative Equilibrium Price
138
Indicative Equilibrium Volume
91

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
INOV
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Inocycle Technology Group Tbk.

PT Inocycle Technology Group Tbk (The Company) formerly known PT Hilon Felt (the “Company”) was established based on Deed of Establishment No. 35 dated 17 July 2001 which was made in the presence of Fransiscus Xaverius Budi Santoso Isbandi, S.H., a notary in Jakarta.

Read more on INOV